Therapy of type 2 diabetes, cardiovascular death, and the UGDP

Am Heart J. 1999 Nov;138(5 Pt 1):S346-52. doi: 10.1016/s0002-8703(99)70034-7.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Angioplasty, Balloon, Coronary
  • Blood Glucose / metabolism
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / mortality*
  • Cardiovascular Diseases / therapy
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Double-Blind Method
  • Female
  • Glucose Tolerance Test
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Insulin / therapeutic use*
  • Male
  • Middle Aged
  • Phenformin / therapeutic use*
  • Prospective Studies
  • Risk Factors
  • Survival Rate
  • Tolbutamide / therapeutic use*
  • Treatment Outcome
  • Universities

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin
  • Tolbutamide
  • Phenformin